The Japan unit of US pharmaceutical giant Johnson & Johnson and a Tokyo-based firm selling medical products were searched by the country’s antitrust watchdog over potential violations of the antimonopoly law, sources close to the matter said Tuesday.
The Japan Fair Trade Commission suspects Johnson & Johnson K.K. and ASP Japan of obstructing competitors’ sales of cleaners and disinfectants for endoscopes.
Related: Pfizer, Johnson & Johnson Settle High-Profile Remicade Antitrust Suit
ASP Japan said on its website that it was formerly under Johnson & Johnson until 2019 and specializes in infection prevention technology.
According to the sources, the companies allegedly required that only their disinfectants be used in endoscope cleaners that their trading partners produce. They are also believed to have created equipment maintenance contracts with hospitals that stipulate using their disinfectants.
The commission said it is looking into possible obstruction of trading and forced buying of tie-in products. Japan’s antimonopoly law bans both practices.
Featured News
New UK Legislation to Combat Ticket Resale and Algorithmic Price-Fixing
Jan 12, 2025 by
CPI
Supreme Court Justices Grill TikTok’s Lawyer in National Security Case
Jan 12, 2025 by
CPI
FTC, DOJ Weigh Antitrust Issues in Musk’s OpenAI Case
Jan 12, 2025 by
CPI
UK Trial Begins as Apple Defends App Store Fees in £1.5 Billion Case
Jan 12, 2025 by
CPI
Italy to Retain Full Control of Data in Potential Deal with Musk’s Starlink
Jan 12, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand